Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle - PubMed (original) (raw)

. 2012 Oct;90(10):1145-60.

doi: 10.1007/s00109-012-0887-y. Epub 2012 Mar 13.

J C von Kleist-Retzow, M Böse, C Sanchez-Lasheras, S Brodesser, O Krut, W S Kunz, D Wiedermann, M Hoehn, O Stöhr, L Moll, S Freude, W Krone, M Schubert, R J Wiesner

Affiliations

Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle

A Franko et al. J Mol Med (Berl). 2012 Oct.

Abstract

The role of mitochondrial dysfunction in the development of insulin resistance and type 2 diabetes remains controversial. In order to specifically define the relationship between insulin receptor (InsR) signaling, insulin resistance, hyperglycemia, hyperlipidemia and mitochondrial function, we analyzed mitochondrial performance of insulin-sensitive, slow-oxidative muscle in four different mouse models. In obese but normoglycemic ob/ob mice as well as in obese but diabetic mice under high-fat diet, mitochondrial performance remained unchanged even though intramyocellular diacylglycerols (DAGs), triacylglycerols (TAGs), and ceramides accumulated. In contrast, in muscle-specific InsR knockout (MIRKO) and streptozotocin (STZ)-treated hypoinsulinemic, hyperglycemic mice, levels of mitochondrial respiratory chain complexes and mitochondrial function were markedly reduced. In STZ, but not in MIRKO mice, this was caused by reduced transcription of mitochondrial genes mediated via decreased PGC-1α expression. We conclude that mitochondrial dysfunction is not causally involved in the pathogenesis of obesity-associated insulin resistance under normoglycemic conditions. However, obesity-associated type 2 diabetes and accumulation of DAGs or TAGs is not associated with impaired mitochondrial function. In contrast, chronic hypoinsulinemia and hyperglycemia as seen in STZ-treated mice as well as InsR deficiency in muscle of MIRKO mice lead to mitochondrial dysfunction. We postulate that decreased mitochondrial mass and/or performance in skeletal muscle of non-diabetic, obese or type 2 diabetic, obese patients observed in clinical studies must be explained by genetic predisposition, physical inactivity, or other still unknown factors.

PubMed Disclaimer

References

    1. Diabetes. 2007 Nov;56(11):2683-9 - PubMed
    1. Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):6028-33 - PubMed
    1. Biochem Biophys Res Commun. 2006 Nov 10;350(1):202-7 - PubMed
    1. Nat Med. 2009 Nov;15(11):1307-11 - PubMed
    1. J Clin Invest. 2011 Jun;121(6):2457-61 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources